
About Reviva Pharmaceuticals India Private Limited
Data last updated:
Reviva Pharmaceuticals India Private Limited is a foreign private limited company based in Bangalore, Karnataka, India, a subsidiary of Reviva Pharmaceuticals Inc. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 23 December 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24233KA2014FTC077889. Its GSTIN is 29AAHCR1571M1ZV (Karnataka).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Krishnamurthy Ramachandra Bhat and Laxminarayan Bhat.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Level 8 Tower 1 Umiya Business Bay Cessna Business Park, Bangalore, Karnataka.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.43 Cr, a decline of 11% compared to the previous year. For the same year it recorded a net profit of ₹46.99 Lakh (net margin 13.7%) and EBITDA of ₹66.87 Lakh (EBITDA margin 19.5%). Revenue has grown at a compounded annual rate (CAGR) of 99% over three years.
The company is associated with 1 brand: Reviva Pharmaceuticals.
The current compliance status is marked as active non-compliant by the Registrar of Companies. For more details, the company can be reached via its website revivapharma.com.
Company details
Contact details
Reviva Pharmaceuticals India Private Limited's registered office is in Bangalore, Karnataka. Its website is revivapharma.com. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressLevel 8 Tower 1 Umiya Business Bay Cessna Business Park Kadubeesanahalli Ma, Rathahalli, Bangalore, Karnataka, India – 560103
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Reviva Pharmaceuticals India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Reviva Pharmaceuticals India operates one associated brand: Reviva Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Therapeutic drugs for central nervous system disorders are developed. | revivapharma.com |
Business activity
The main business activity of Reviva Pharmaceuticals India is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Reviva Pharmaceuticals India Private Limited, buy the company report.
Financials of Reviva Pharmaceuticals India Private Limited
FY 2025 filings availableReviva Pharmaceuticals India Private Limited reported revenue of ₹3.43 Cr (down 11% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 11% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 99%. EBITDA rose 50% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹66.87 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹46.99 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 19.5% | ||||
| Net Profit Margin | 13.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Reviva Pharmaceuticals India Private Limited, buy the company report.
Board of directors of Reviva Pharmaceuticals India Private Limited
Reviva Pharmaceuticals India has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Krishnamurthy Ramachandra Bhat | Director | 23 Dec 2014 | 11 Years 10 Months | Current |
| Laxminarayan Bhat | Director | 23 Dec 2014 | 11 Years 10 Months | Current |
Auditor
Reviva Pharmaceuticals India Private Limited is audited by NIKHIL VYAS & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| NIKHIL VYAS & ASSOCIATES | FY 2020 | 015076S |
Shareholding
The shareholding of Reviva Pharmaceuticals India Private Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Reviva Pharmaceuticals India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Reviva Pharmaceuticals India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Reviva Pharmaceuticals India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Reviva Pharmaceuticals India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAHCR1571M1ZV | Karnataka | Active | 05 Jan 2019 |
To see the full GST registrations and return filing status of Reviva Pharmaceuticals India Private Limited, buy the company report.
Recent activity
Reviva Pharmaceuticals India Private Limited has 2 board changes on record since 2014: 2 appointments. The latest: Krishnamurthy Ramachandra Bhat was appointed as Director on 23 Dec 2014.
News
Frequently asked questions
Reviva Pharmaceuticals India is an active foreign private limited company based in Bangalore, Karnataka, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 23 December 2014 (12+ years old) and is registered under CIN U24233KA2014FTC077889.
Reviva Pharmaceuticals India has 2 current directors:
- Krishnamurthy Ramachandra Bhat - Director
- Laxminarayan Bhat - Director
The latest financial statements of Reviva Pharmaceuticals India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Reviva Pharmaceuticals India is 29AAHCR1571M1ZV, registered in Karnataka.
The CIN (Corporate Identification Number) of Reviva Pharmaceuticals India is U24233KA2014FTC077889. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Reviva Pharmaceuticals India was incorporated on 23 December 2014, making it 12+ years old. It is registered with the Registrar of Companies, Bangalore.
Krishnamurthy Ramachandra Bhat was appointed as Director on 23 Dec 2014. Laxminarayan Bhat was appointed as Director on 23 Dec 2014.
Reviva Pharmaceuticals India can be reached through the website revivapharma.com. Its registered office is in Bangalore, Karnataka, India.
The registered office of Reviva Pharmaceuticals India is at Level 8 Tower 1 Umiya Business Bay Cessna Business Park Kadubeesanahalli Ma, Rathahalli, Bangalore, Karnataka, India – 560103.
Reviva Pharmaceuticals India operates in the pharma industry, in the pharma contract r and d segment.

